Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
thinq-pharma is a forward-thinking pharmaceutical company focused on the discovery, development, and commercialization of innovative medicines. We are committed to addressing unmet medical needs through cutting-edge research and a patient-centric approach. Our pipeline spans multiple therapeutic areas, driven by a passion for science and a dedication to improving global health outcomes. At thinq-pharma, we believe in a collaborative environment that fosters ingenuity and accelerates the delivery of breakthrough treatments to those who need them most.
The headquarters serves as the central nervous system for global operations, R&D strategy, corporate governance, business development, and investor relations.
State-of-the-art research laboratories, collaborative open-plan office spaces designed to foster innovation, and advanced data analytics center.
A dynamic and intellectually stimulating environment that encourages collaboration, critical thinking, and a relentless pursuit of scientific excellence. Employees benefit from cross-functional team interactions and a strong sense of mission.
Its location in Cambridge provides unparalleled access to world-class academic institutions, a rich talent pool, venture capital, and a vibrant ecosystem of biotech peers and potential partners.
thinq-pharma operates globally with key functions distributed across North America, Europe, and Asia-Pacific. This includes R&D centers conducting cutting-edge research, clinical operations managing trials worldwide, manufacturing and supply chain networks ensuring product availability, and commercial teams delivering therapies to patients in numerous countries. Our global strategy allows us to access diverse talent, collaborate with international experts, and address healthcare challenges on a worldwide scale.
700 Technology Square
Cambridge
MA
USA
Address: Lichtstrasse 35, 4056 Basel
To manage European clinical trials, engage with EU regulatory bodies like the EMA, and drive commercialization efforts across Europe.
Address: Building 5, Zhangjiang Pharma Valley, 123 Science Road, Pudong
To expand thinq-pharma's presence in the rapidly growing APAC pharmaceutical market, cater to regional health needs, and tap into local scientific talent.
Address: 10835 Road to the Cure, Suite 200
To lead cutting-edge research in genetic therapies and precision medicine, leveraging the strong life sciences ecosystem in Southern California.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, THINQ Pharma' leadership includes:
THINQ Pharma has been backed by several prominent investors over the years, including:
Over the past year, thinq-pharma has strategically strengthened its leadership team with key appointments, notably in commercial operations, while also seeing a planned transition in its R&D leadership.
Discover the tools THINQ Pharma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
thinq-pharma commonly utilizes email formats such as [first_initial][last]@thinq-pharma.com (e.g., jdoe@thinq-pharma.com) or [first].[last]@thinq-pharma.com (e.g., jane.doe@thinq-pharma.com). The specific format may vary by department or region.
[first_initial][last]@thinq-pharma.com or [first].[last]@thinq-pharma.com
Format
athorne@thinq-pharma.com
Example
90%
Success rate
PharmaTimes • April 15, 2024
thinq-pharma announced encouraging topline results from its pivotal Phase III study (THN-AD-003) evaluating TP-205, its novel therapeutic candidate for early-stage Alzheimer's disease. The study met its primary and key secondary endpoints, demonstrating statistically significant cognitive benefits....more
Endpoints News • January 22, 2024
thinq-pharma successfully closed a $150 million Series C financing round led by Catalyst Ventures, with participation from existing and new investors. The funds will be used to advance its lead candidates through late-stage clinical trials and expand its discovery research platform....more
FierceBiotech • November 08, 2023
thinq-pharma and Genentech, a member of the Roche Group, announced a strategic research collaboration and license agreement to discover and develop novel bispecific antibodies targeting challenging cancer pathways. thinq-pharma will receive an upfront payment and is eligible for milestone payments and royalties....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including THINQ Pharma, are just a search away.